SENHWA BIOSCIENCES, INC.
Update：2026/08/06
Industries
Main Industry
Biotechnology
Main Product/Service
1. G-quadruplex (stabilizer)
2. Casein Kinase 2 (inhibitor)
2. Casein Kinase 2 (inhibitor)
Founded Year
2012
Unified Business No.
54021973
Status
Active
Number of Employees
0
Total Paid-in
Capital
899,036,200 (NT$)
Location of Company
Taiwan
, New Taipei City
Exit Status
OTC listing(2017)
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Senhwa Biosciences Inc. was established in 2012 and listed on the Taipei Exchange (TPEx) on April 24, 2017. The company aims to transform the model for new drug development by focusing on human efficacy. Senhwa believes that its dedication to science and rigorous processes will enable Senhwa to achieve remarkable milestones.
